GENETIC ENGINEERING & BIOTECHNOLOGY NEWS

Junevity co-founders Janine Sengstack & Rob Cahill share a foundational perspective on why transcription factors, once dismissed as “undruggable” and “too risky,” are now within reach thanks to advances in siRNA, omics, and AI/ML.

How siRNA, omics, and AI could enable 100 new FDA approvals by 2045

Read here: https://www.genengnews.com/topics/drug-discovery/unlocking-the-potential-of-transcription-factors/